Chromosome Analysis, Amniotic Fluid
- GTR Test IDHelpEach Test is a specific, orderable test from a particular laboratory, and is assigned a unique GTR accession number. The format is GTR00000001.1, with a leading prefix 'GTR' followed by 8 digits, a period, then 1 or more digits representing the version. When a laboratory updates a registered test, a new version number is assigned.: GTR000593807.4
- Last updated: 2022-08-12
- Test version history
Clinical testHelpIn the U.S., clinical tests must be performed under CLIA certification. When a lab uses the same methods for a test in both clinical and research settings, the test appears as two separate GTR records. for Congenital chromosomal disease
Offered by Institute for Genomic Medicine (IGM) Clinical Laboratory
- ACMG, 2021Chromosomal microarray analysis, including constitutional and neoplastic disease applications, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG)
- NSGC, 2021National Society of Genetic Counselors Position Statement: Prenatal Cell-Free DNA Screening
- ACMG, 2016Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics
- ESHG/ASHG, 2015Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening.
- NSGC, 2013Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the National Society of Genetic Counselors. (Replaced by NSCG, 2021 Statement)
- ACMG, 2013ACMG statement on noninvasive prenatal screening for fetal aneuploidy. (See 2016 Update)
- ICFMM, 2013Position Statement from the Italian College of Fetal Maternal Medicine: Non-invasive prenatal testing (NIPT) by maternal plasma DNA sequencing.
- NSGC, 2013NSGC practice guideline: prenatal screening and diagnostic testing options for chromosome aneuploidy.
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.